Valeant beats Merz in the battle for Obagi

26 April 2013 - Deborah Wilkes

Archived

Valeant Pharmaceuticals International has acquired Obagi Medical Products, after raising its takeover offer by more than a fifth to around US$420 million.

Click tags below for more information on topics:

Merz

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: